Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Jacques Body

Showing results (91-100 of 133) with videos related to

Pageof 14
Sort By:
Journal of Bone Oncology|December 24, 2016
Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countriesJean-Jacques Body, Yves Pascal Acklin, Oliver Gunther, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 22, 2017
An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countriesJean-Jacques Body, Francesca Gatta, Erwin De Cock, et al.
Archives of Osteoporosis|December 23, 2022
External validation of FRISBEE 5-year fracture prediction models: a registry-based cohort studyArnav Agarwal, Felicia Baleanu, Michel Moreau, et al.
European Geriatric Medicine|July 18, 2025
Osteosarcopenia, sarcopenia, and their associations with validated recent fragility fractures in older women: applying seven definitions in the FRISBEE 2 studyDolores Sanchez-Rodriguez, Amelie Bellanger, Laura Iconaru, et al.
The Journal of Clinical Endocrinology and Metabolism|February 17, 2022
Fragility Fractures in Postmenopausal Women: Development of 5-Year Prediction Models Using the FRISBEE StudyFelicia Baleanu, Michel Moreau, Alexia Charles, et al.
Clinical and Translational Science|February 18, 2026
A Randomized Phase 1 Study Comparing the PK, PD, Safety, and Immunogenicity of Proposed Biosimilar RGB-14-X and Denosumab in Healthy Adult MalesEmmanuel Biver, Jean-Jacques Body, Ashwin Sachdeva, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 7, 2021
Prediction of an Imminent Fracture After an Index Fracture - Models Derived From the Frisbee CohortLaura Iconaru, Alexia Charles, Felicia Baleanu, et al.
Clinical Biochemistry|September 17, 2004
Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzerDiana L Ersfeld, D Sudhaker Rao, Jean-Jacques Body, et al.
Calcified Tissue International|October 9, 2015
Effects of Dairy Products Consumption on Health: Benefits and Beliefs--A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal DiseasesSerge Rozenberg, Jean-Jacques Body, Olivier Bruyère, et al.
Critical Reviews in Oncology/Hematology|March 18, 2011
Consensus on the utility of bone markers in the malignant bone disease settingRobert Coleman, Luis Costa, Fred Saad, et al.
Pageof 14

Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
Journal of Bone Oncology|December 24, 2016
Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countriesJean-Jacques Body, Yves Pascal Acklin, Oliver Gunther, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 22, 2017
An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countriesJean-Jacques Body, Francesca Gatta, Erwin De Cock, et al.
Archives of Osteoporosis|December 23, 2022
External validation of FRISBEE 5-year fracture prediction models: a registry-based cohort studyArnav Agarwal, Felicia Baleanu, Michel Moreau, et al.
European Geriatric Medicine|July 18, 2025
Osteosarcopenia, sarcopenia, and their associations with validated recent fragility fractures in older women: applying seven definitions in the FRISBEE 2 studyDolores Sanchez-Rodriguez, Amelie Bellanger, Laura Iconaru, et al.
The Journal of Clinical Endocrinology and Metabolism|February 17, 2022
Fragility Fractures in Postmenopausal Women: Development of 5-Year Prediction Models Using the FRISBEE StudyFelicia Baleanu, Michel Moreau, Alexia Charles, et al.
Clinical and Translational Science|February 18, 2026
A Randomized Phase 1 Study Comparing the PK, PD, Safety, and Immunogenicity of Proposed Biosimilar RGB-14-X and Denosumab in Healthy Adult MalesEmmanuel Biver, Jean-Jacques Body, Ashwin Sachdeva, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 7, 2021
Prediction of an Imminent Fracture After an Index Fracture - Models Derived From the Frisbee CohortLaura Iconaru, Alexia Charles, Felicia Baleanu, et al.
Clinical Biochemistry|September 17, 2004
Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzerDiana L Ersfeld, D Sudhaker Rao, Jean-Jacques Body, et al.
Calcified Tissue International|October 9, 2015
Effects of Dairy Products Consumption on Health: Benefits and Beliefs--A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal DiseasesSerge Rozenberg, Jean-Jacques Body, Olivier Bruyère, et al.
Critical Reviews in Oncology/Hematology|March 18, 2011
Consensus on the utility of bone markers in the malignant bone disease settingRobert Coleman, Luis Costa, Fred Saad, et al.
Pageof 14